Dr Alasdair Hubbard is a Lecturer in Microbiology at Nottingham Trent University and has a background in molecular microbiology and experimental evolution, with significant experience in AMR. The focus of Alasdair’s research group is to further understand and explore the evolution of AMR during treatment of urinary tract infections. The group aims to achieve this by using physiologically relevant in vitro models which represent the human bladder to evolve clinical isolates of UTI pathogens, with a particular focus on Escherichia coli, to clinically relevant antibiotics. By assessing the phenotypic characteristics of AMR mutants using evolutionary principles (e.g. collateral susceptibility, mutant selection windows, etc) they aim to optimise antimicrobial regimens to limit the emergence of AMR, reduce rates of recurrence of infection and improve treatment options and outcomes. Alasdair is a long-standing member of the Microbiology Society and British Society of Antimicrobial Chemotherapy and has a keen interest in using laboratory data to influence policy.